Avant Brands Closes $3.9 Million Offering of Unsecured Convertible Debenture Units

Rhea-AI Summary

Avant Brands (TSX:AVNT)(OTCQX:AVTBF) has successfully closed a $3.9 million non-brokered private placement of unsecured convertible debenture units. Each unit, priced at $1,000, comprises a $1,000 principal amount convertible debenture and 10,000 common share purchase warrants. The debentures are convertible at $0.10 per share and bear a 10% annual interest rate. Warrants are exercisable at $0.10 per share for 48 months. The company plans to use the proceeds to repay existing debt. CEO Norton Singhavon views this as a significant milestone, potentially enabling expansion into international markets and accelerating growth.

Positive

• Successful closing of $3.9 million private placement
• 10% annual interest rate on convertible debentures
• Warrants exercisable for 48 months, providing long-term potential for investors
• Proceeds to be used for debt repayment, potentially improving the company's financial position

Negative

• Issuance of convertible securities may lead to potential dilution for existing shareholders
• High 10% interest rate on debentures indicates relatively high cost of capital
• Quarterly repayment of 6.25% of principal amount may strain cash flow

KELOWNA, BC / ACCESSWIRE / July 29, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, is pleased to announce that it has closed its non-brokered private placement (the "Offering") in the amount of $3,900,000 priced at a price of $1,000 per unsecured convertible debenture unit through the issuance of 3,900 unsecured convertible debenture units (the "Convertible Debenture Units"). The net proceeds raised from the Offering are expected to be used to repay existing indebtedness.

Norton Singhavon, Founder and CEO of Avant Brands commented:

"This investment is a major milestone for Avant Brands, demonstrating the growing recognition of our brand and potential. We are confident that this capital infusion will enable us to further expand our reach into key international markets and accelerate our overall growth trajectory, contributing to the generation of long-term value for our shareholders."

Each Convertible Debenture Unit is comprised of (i) $1,000 principal amount (the "Principal Amount") of senior unsecured convertible debentures (the "Convertible Debentures") of the Company and (ii) 10,000 common share purchase warrants (the "Warrants") of the Company. Each Convertible Debenture will be convertible into common shares of the Company (the "Debenture Shares"), at the option of the holder at a conversion price of $0.10 per Debenture Share, subject to adjustment in certain circumstances. Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") at a price of $0.10 per Warrant Share for a period of 48 months from July 26, 2024 (the "Closing Date").

The Convertible Debentures bear interest at a rate of 10% per annum from the Closing Date, calculated and payable quarterly in cash, with any remaining accrued and unpaid interest to be paid by the Company on the fourth anniversary of the Closing Date (the "Maturity Date"). The Company is expected to (i) repay 6.25% of the Principal Amount quarterly in cash, and (ii) repay the remaining Principal Amount outstanding on the Maturity Date.

Pursuant to the terms of the Convertible Debentures and the Warrants, the holder will be restricted from converting or exercising the Convertible Debentures or Warrants, as applicable, to the extent that after giving effect to such conversion or exercise, as the case may be, the holder would beneficially own or exercise control or direction over, directly or indirectly in excess of 9.99% of the common shares of the Company outstanding immediately after giving effect to such conversion or exercise, as the case may be.

About Avant Brands Inc.

Avant is an innovative, market-leading premium cannabis company. Avant has multiple operational production facilities across Canada, which produce high-quality, handcrafted cannabis products based on unique and exceptional cultivars.

Avant offers a comprehensive product portfolio catering to recreational, medical, and export markets. Avant's consumer brands, including BLK MKT™, Tenzo™, Cognōscente™, flowr™ and Treehugger™, are available in key recreational markets across Canada. Avant's products are distributed globally to Australia, Israel and Germany, with its flagship brand BLK MKT™ currently being sold in Israel. Additionally, Avant's medical cannabis brand, GreenTec™, serves qualified patients nationwide through its GreenTec Medical portal and trusted medical cannabis partners.

Avant is a publicly traded corporation listed on the TSX (TSX:AVNT) and accessible to international investors through the OTCQX Best Market (OTCQX:AVTBF) and Frankfurt Stock Exchange (FRA: 1BU0). Headquartered in Kelowna, British Columbia, Avant operates in strategic locations including British Columbia, Alberta, and Ontario.

For more information about Avant, including access to investor presentations and details about its consumer brands, please visit www.avantbrands.ca

For further inquiries, please contact:
Investor Relations at Avant Brands Inc.
1-800-351-6358
ir@avantbrands.ca

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain "forward-looking information" as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding the expected use of proceeds. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: risk related to the ability to obtain additional financing; limited operating history; regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Company's annual information form dated February 28, 2024, filed with Canadian securities regulators and available on the Company's profile on SEDAR+ at www.sedarplus.ca.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speak only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Avant Brands Inc.

View the original press release on accesswire.com

FAQ

What is the size and purpose of Avant Brands' recent private placement?

Avant Brands (AVTBF) closed a $3.9 million non-brokered private placement on July 29, 2024. The proceeds are expected to be used to repay existing indebtedness.

What are the key terms of Avant Brands' convertible debentures issued on July 26, 2024?

The convertible debentures bear 10% annual interest, are convertible at $0.10 per share, and mature in four years. The company will repay 6.25% of the principal amount quarterly and the remaining balance at maturity.

How long can investors exercise the warrants issued by Avant Brands in July 2024?

Investors can exercise the warrants issued by Avant Brands (AVTBF) for a period of 48 months from July 26, 2024, at a price of $0.10 per warrant share.

What restrictions are placed on the conversion of Avant Brands' debentures and warrants?

Holders are restricted from converting debentures or exercising warrants if it would result in them owning or controlling more than 9.99% of Avant Brands' (AVTBF) outstanding common shares.